Related Experiment Video
Updated: May 19, 2026

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
Published on: August 14, 2012
Human neuroendocrine tumor cell lines as a three-dimensional model for the study of human neuroendocrine tumor
Chung Wong1, Evan Vosburgh, Arnold J Levine
1Raymond and Beverly Sackler Foundation.
Abstract:
Neuroendocrine tumors (NETs) are rare tumors, with an incidence of two per 100, 000 individuals per year, and they account for 0.5% of all human malignancies. Other than surgery for the minority of patients who present with localized disease, there is little or no survival benefit of systemic therapy. Therefore, there is a great need to better understand the biology of NETs, and in particular define new therapeutic targets for patients with nonresectable or metastatic neuroendocrine tumors. 3D cell culture is becoming a popular method for drug screening due to its relevance in modeling the in vivo tumor tissue organization and microenvironment. The 3D multicellular spheroids could provide valuable information in a more timely and less expensive manner than directly proceeding from 2D cell culture experiments to animal (murine) models. To facilitate the discovery of new therapeutics for NET patients, we have developed an in vitro 3D multicellular spheroids model using the human NET cell lines. The NET cells are plated in a non-adhesive agarose-coated 24-well plate and incubated under physiological conditions (5% CO2, 37 °C) with a very slow agitation for 16-24 hr after plating. The cells form multicellular spheroids starting on the 3(rd) or 4(th) day. The spheroids become more spherical by the 6(th) day, at which point the drug treatments are initiated. The efficacy of the drug treatments on the NET spheroids is monitored based on the morphology, shape and size of the spheroids with a phase-contrast light microscope. The size of the spheroids is estimated automatically using a custom-developed MATLAB program based on an active contour algorithm. Further, we demonstrate a simple method to process the HistoGel embedding on these 3D spheroids, allowing the use of standard histological and immunohistochemical techniques. This is the first report on generating 3D spheroids using NET cell lines to examine the effect of therapeutic drugs. We have also performed histology on these 3D spheroids, and displayed an example of a single drug's effect on growth and proliferation of the NET spheroids. Our results support that the NET spheroids are valuable for further studies of NET biology and drug development.
Insights
This study introduces a novel 3D multicellular spheroid model using neuroendocrine tumor (NET) cell lines. This 3D model aids in discovering new therapeutic targets and evaluating drug efficacy for NET patients.
Area of Science:
- Oncology
- Biotechnology
- Drug Discovery
Background:
- Neuroendocrine tumors (NETs) are rare malignancies with limited systemic therapy options.
- Developing new therapeutic targets for NETs is crucial, especially for advanced disease.
- 3D cell culture models offer a more in vivo-like platform for studying tumor biology and drug screening.
Purpose of the Study:
- To develop and validate an in vitro 3D multicellular spheroid model using human NET cell lines.
- To establish a platform for efficient drug screening and evaluation of therapeutic targets in NETs.
- To facilitate the discovery of novel treatments for patients with nonresectable or metastatic neuroendocrine tumors.
Main Methods:
- Human NET cell lines were cultured in non-adhesive agarose-coated plates under physiological conditions with slow agitation.
- Multicellular spheroids formed within 3-4 days and were treated with drugs on day 6.
- Drug efficacy was assessed via microscopy, and spheroid size was quantified using a custom MATLAB program.
- HistoGel embedding was utilized for standard histological and immunohistochemical analyses of the 3D spheroids.
Main Results:
- A reproducible method for generating 3D multicellular spheroids from NET cell lines was established.
- The 3D spheroid model allowed for morphological and size-based monitoring of drug treatment efficacy.
- Histological analysis of the 3D spheroids was demonstrated, showcasing drug effects on growth and proliferation.
Conclusions:
- The developed 3D NET spheroid model is a valuable tool for advancing neuroendocrine tumor research.
- This model provides a more relevant and efficient platform for drug discovery and development in NETs.
- The findings support the utility of this 3D model for future studies on NET biology and therapeutic interventions.

